688363 華熙生物
按盤價 
35.450 -0.450 (-1.253%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 0.910 | 4.204 | 2.534 | 8.728 | 15.745 |
| 總資產報酬率 ROA (%) | 0.741 | 3.367 | 2.035 | 6.910 | 11.997 |
| 投入資產回報率 ROIC (%) | 0.854 | 3.963 | 2.411 | 8.259 | 14.678 | 邊際利潤分析 |
| 銷售毛利率 (%) | 67.837 | 70.329 | 74.071 | 73.320 | 76.990 |
| 營業利潤率 (%) | 8.548 | 7.932 | 4.021 | 11.659 | 17.869 |
| 息稅前利潤/營業總收入 (%) | 9.825 | 7.830 | 3.844 | 11.042 | 17.101 |
| 淨利潤/營業總收入 (%) | 7.837 | 6.934 | 3.136 | 9.591 | 15.118 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 112.745 | 111.811 | 155.071 | 90.875 | 91.276 |
| 價值變動淨收益/利潤總額(%) | -8.081 | 4.240 | -5.212 | 0.398 | 1.036 |
| 營業外收支淨額/利潤總額(%) | -4.232 | 0.213 | -1.193 | -0.950 | -0.018 | 償債能力分析 |
| 流動比率 (X) | 2.362 | 2.340 | 2.044 | 2.558 | 2.447 |
| 速動比率 (X) | 1.595 | 1.516 | 1.113 | 1.629 | 1.741 |
| 資產負債率 (%) | 18.176 | 18.146 | 20.989 | 17.551 | 23.023 |
| 帶息債務/全部投入資本 (%) | 2.727 | 1.630 | 0.234 | 0.173 | 3.478 |
| 股東權益/帶息債務 (%) | 3,418.063 | 5,796.133 | 40,161.142 | 55,551.426 | 2,675.714 |
| 股東權益/負債合計 (%) | 448.306 | 449.210 | 374.818 | 467.119 | 331.894 |
| 利息保障倍數 (X) | 6.051 | -65.515 | -29.680 | -21.787 | -22.350 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 63.070 | 47.468 | 33.188 | 26.538 | 23.920 |
| 存貨周轉天數 (天) | 322.230 | 321.938 | 307.927 | 254.954 | 230.122 |
| 備註： | 即時報價更新時間為 18/06/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
